Bowhead’s Sills on MGAs: 'Most of those start-ups will not have legs'
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Bowhead’s Sills on MGAs: 'Most of those start-ups will not have legs'

Farhin Lilywala
April 19, 2022
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
handshake money m&a.jpg

Bowhead Specialty CEO Stephen Sills questioned the long-term viability of some newly formed MGAs and start-ups, especially in the casualty and D&O spaces, that may not be able to withstand a downturn of rates, or an increase in severity.

The executive told Inside P&C that there has been an “alphabet soup of MGAs” that have started in the past year, “which I am not convinced are going to have legs".

“You

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Specialty lines D&O (Directors and Officers) Medmal (Medical malpractice) SPACs IPOs
farhin lilywala/farhin lilywala ii us.png
Farhin Lilywala
Section Editor, Distribution & Specialty
Contact
Gift this article